BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23871228)

  • 1. Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.
    Chambers RP; Call GB; Meyer D; Smith J; Techau JA; Pearman K; Buhlman LM
    Behav Brain Res; 2013 Sep; 253():95-102. PubMed ID: 23871228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline protects, rescues and prevents knockdown transgenic parkin Drosophila against paraquat/iron toxicity: Implications for autosomic recessive juvenile parkinsonism.
    Ortega-Arellano HF; Jimenez-Del-Rio M; Velez-Pardo C
    Neurotoxicology; 2017 May; 60():42-53. PubMed ID: 28284907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels.
    Carvajal-Oliveros A; Domínguez-Baleón C; Zárate RV; Campusano JM; Narváez-Padilla V; Reynaud E
    Sci Rep; 2021 May; 11(1):9579. PubMed ID: 33953275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A locomotor assay reveals deficits in heterozygous Parkinson's disease model and proprioceptive mutants in adult
    Aggarwal A; Reichert H; VijayRaghavan K
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24830-24839. PubMed ID: 31748267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary management and physical exercise can improve climbing defects and mitochondrial activity in Drosophila melanogaster parkin null mutants.
    Bajracharya R; Ballard JWO
    Fly (Austin); 2018; 12(2):95-104. PubMed ID: 30068249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways.
    Saini N; Oelhafen S; Hua H; Georgiev O; Schaffner W; Büeler H
    Neurobiol Dis; 2010 Oct; 40(1):82-92. PubMed ID: 20483372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
    Park J; Lee SB; Lee S; Kim Y; Song S; Kim S; Bae E; Kim J; Shong M; Kim JM; Chung J
    Nature; 2006 Jun; 441(7097):1157-61. PubMed ID: 16672980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerable Parkin Loss-of-Function
    Cackovic J; Gutierrez-Luke S; Call GB; Juba A; O'Brien S; Jun CH; Buhlman LM
    Front Cell Neurosci; 2018; 12():39. PubMed ID: 29497364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: implication in autosomal recessive juvenile parkinsonism.
    Bonilla-Ramirez L; Jimenez-Del-Rio M; Velez-Pardo C
    Gene; 2013 Jan; 512(2):355-63. PubMed ID: 23046578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Julienne H; Buhl E; Leslie DS; Hodge JJL
    Neurobiol Dis; 2017 Aug; 104():15-23. PubMed ID: 28435104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
    Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
    Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low protein to carbohydrate ratio diet delays onset of Parkinsonism like phenotype in Drosophila melanogaster parkin null mutants.
    Bajracharya R; Ballard JW
    Mech Ageing Dev; 2016 Dec; 160():19-27. PubMed ID: 27720857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.
    Haywood AF; Staveley BE
    BMC Neurosci; 2004 Apr; 5():14. PubMed ID: 15090075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
    Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
    Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.
    Greene JC; Whitworth AJ; Kuo I; Andrews LA; Feany MB; Pallanck LJ
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4078-83. PubMed ID: 12642658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.